The American Medical Association (AMA) has announced the appointment of Dr. Kirsten Bibbins-Domingo as the next editor-in-chief of the Journal of the American Medical Association (JAMA) and JAMA Network™. Dr. Bibbins-Domingo is the Lee Goldman, M.D,. Endowed Professor of Medicine and chair of the Department of Epidemiology and Biostatistics at the UCSF School of Medicine. She was also the inaugural vice dean for population health and health equity at the UCSF School of Medicine, and co-founded the UCSF Center for Vulnerable Populations at the Zuckerberg San Francisco General Hospital. Dr. Bibbins-Domingo will begin her tenure on July 1, 2022, succeeding Dr. Phil Fontanarosa, who has served as interim editor-in-chief since March 2021.
Dr. Bibbins-Domingo was a member of the U.S. Preventive Services Task Force from 2010-2017 and led the Task Force as the vice-chair and chair from 2014-2017. In this leadership role, she led the Task Force’s editorial process of a systematic review of evidence, authorship of clinical guidelines, and multi-channel publication of evidence and guidelines to physicians and patients.
Dr. Bibbins-Domingo began her career as a biochemist, having trained in the laboratory of the Nobelist Harold Varmus and currently serves as a general internist, cardiovascular disease epidemiologist, and a national leader in prevention and interventions to address health disparities. She is an NIH-funded researcher who uses observational studies, pragmatic trials, and simulation modeling to examine effective clinical, public health, and policy interventions aimed at prevention.
Dr. Bibbins-Domingo is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.
Click here to read the original press release.
